Evidence map›Paper›PMID 37473758›Full record

ArticleNeuron2023

Excitatory neuron-specific suppression of the integrated stress response contributes to autism-related phenotypes in fragile X syndrome.

Mehdi Hooshmandi, Vijendra Sharma, Carolina Thörn Perez, Rapita Sood, Konstanze Krimbacher, Calvin Wong, Kevin C Lister, Alba Ureña Guzmán, Trevor D Bartley, Cecilia Rocha and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Biomolecules · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 12 institutions in 5 countries.

Mehdi HooshmandiDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Vijendra SharmaDepartment of Biochemistry, McGill University, Montréal, QC, Canada.
Carolina Thörn PerezDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Rapita SoodDepartment of Biochemistry, McGill University, Montréal, QC, Canada.
Konstanze KrimbacherDepartment of Pharmacology, Medical University Innsbruck, 6020 Innsbruck, Austria.
Calvin WongDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Kevin C ListerDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Alba Ureña GuzmánDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Trevor D BartleyDepartment of Pathology and Laboratory Medicine, UC Davis School of Medicine, Institute for Pediatric Regenerative Medicine and Shriners Hospitals for Children of Northern California, MIND Institute, UC Davis Medical Center, Sacramento, CA, USA.
Cecilia RochaThe Neuro's Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.
Gilles MaussionThe Neuro's Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.
Emma NadlerDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Patricia Margarita RoqueDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada.
Ilse GantoisDepartment of Biochemistry, McGill University, Montréal, QC, Canada.
Jelena PopicDepartment of Biochemistry, McGill University, Montréal, QC, Canada.
Maxime LévesqueMontreal Neurological Institute-Hospital, Departments of Neurology & Neurosurgery and of Physiology, McGill University, Montréal, QC, Canada.
Randal J KaufmanDegenerative Diseases Program, Center for Genetic Disorders and Aging Research, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Massimo AvoliMontreal Neurological Institute-Hospital, Departments of Neurology & Neurosurgery and of Physiology, McGill University, Montréal, QC, Canada.
Elisenda SanzDepartment of Cell Biology, Physiology and Immunology, and Neuroscience Institute, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Karim NaderDepartment of Psychology, Faculty of Science, McGill University, Montréal, QC, Canada.
Randi Jenssen HagermanMIND Institute and Department of Pediatrics, University of California at Davis Medical Center, Sacramento, CA, USA.
Thomas M DurcanThe Neuro's Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.
Mauro Costa-MattioliDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, 77098, USA.
Masha Prager-KhoutorskyDepartment of Physiology, McGill University, Montréal, QC, Canada.
Jean-Claude LacailleDepartment of Neurosciences, Center for Interdisciplinary Research on Brain and Learning, and Research Group on Neural Signaling and Circuitry, Université de Montréal, Montréal, QC, Canada.
Veronica Martinez-CerdenoDepartment of Pathology and Laboratory Medicine, UC Davis School of Medicine, Institute for Pediatric Regenerative Medicine and Shriners Hospitals for Children of Northern California, MIND Institute, UC Davis Medical Center, Sacramento, CA, USA.
Jay R GibsonUniversity of Texas Southwestern Medical Center at Dallas, Department of Neuroscience, Dallas, TX 75390-9111, USA.
Kimberly M HuberUniversity of Texas Southwestern Medical Center at Dallas, Department of Neuroscience, Dallas, TX 75390-9111, USA.
Nahum SonenbergDepartment of Biochemistry, McGill University, Montréal, QC, Canada. Electronic address: nahum.sonenberg@mcgill.ca.
Christos G GkogkasBiomedical Research Institute, Foundation for Research and Technology-Hellas, University Campus, 45110 Ioannina, Greece. Electronic address: cgkogkas@bri.forth.gr.
Arkady KhoutorskyDepartment of Anesthesia and Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montréal, QC, Canada; Alan Edwards Centre for Research on Pain, McGill University, Montréal, QC, Canada. Electronic address: arkady.khoutorsky@mcgill.ca.
McGill University · CAMontreal Neurological Institute and Hospital · CAShriners Hospitals for Children - Erie · USThe University of Texas Southwestern Medical Center · USBaylor College of Medicine · USCentre for Research on Brain Language and Music · CAFoundation for Research and Technology Hellas · GRInnsbruck Medical University · ATMcGill University Health Centre · CASanford Burnham Prebys Medical Discovery Institute · USUniversitat Autònoma de Barcelona · ESUniversity of California Davis Medical Center · US

Funding

WORKSHOP AND TRAINING ACTIVITIESP41RR018522 · NCRR · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI BELOV, MIKHAIL · 2003 to 2011
$25.1M
Neurophysiological and acute pharmacological studies in FXS patientsU54HD082008 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI HUBER, KIMBERLY M. · 2014 to 2019
$9.8M
Translational medicine and mechanistic studies of brain neurophysiology in Fragile X SyndromeU54HD104461 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI HUBER, KIMBERLY M. · 2020 to 2024
$8.1M
Mechanism of ER Protein Misfolding-Induced Mitochondrial DysfunctionR01DK113171 · NIDDK · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KAUFMAN, RANDAL J. · 2017 to 2020
$2.5M
A Role of Astrocyte and Microglia Interplay in Alzheimer's DiseaseK99AG066960 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI JIANG, LU-LIN · 2020 to 2022
$391k
NCRR NIH HHS P41 RR018522NIA NIH HHS K99 AG066960NICHD NIH HHS U54 HD082008NICHD NIH HHS U54 HD104461NIDDK NIH HHS R01 DK113171
6 · The paper itself

Abstract

Dysregulation of protein synthesis is one of the key mechanisms underlying autism spectrum disorder (ASD). However, the role of a major pathway controlling protein synthesis, the integrated stress response (ISR), in ASD remains poorly understood. Here, we demonstrate that the main arm of the ISR, eIF2α phosphorylation (p-eIF2α), is suppressed in excitatory, but not inhibitory, neurons in a mouse model of fragile X syndrome (FXS; Fmr1

Indexed as

Autism Spectrum DisorderAutistic DisorderFragile X SyndromeAnimalsDisease Models, AnimalFragile X Messenger Ribonucleoprotein 1MiceMice, KnockoutNeuronsPhenotypeFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1autismfragile X syndromeintegrated stress responsemRNA translation

Identifiers

PMID37473758
PMCPMC10592416
OpenAlexW4384830656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.